U.S. Clinical Oncology Next Generation Sequencing (NGS) Market : Deep Research Study with Accurate Forecast by 2025
There are numerous players operating in the U.S. market. To hold their dominant position, many are banking on capitalizing data analysis requirements and need for more robust sequencing platforms through mergers and funding deals between major and minor players.
View full press release